secwatch.observer — SEC 8-K summary
======================================

Issuer:     Orthofix Medical Inc. (OFIX)
CIK:        0000884624
Form:       8-K
Filed at:   2024-11-07T23:59:59+00:00
Accession:  0000950170-24-122777
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Orthofix Q3 net sales $196.6M (+7%), adjusted EBITDA $19.2M, introduces 2027 targets
--------------------------------------------------------------------------------

- Net sales $196.6M, +7% YoY; U.S. Spine Fixation +18%, U.S. Orthopedics record quarter +15%.
- Net loss $(27.4)M vs $(28.9)M prior year; adjusted EBITDA $19.2M, margin 9.8% vs 7.3%.
- Free cash flow positive $5.9M in Q3; new $275M credit facility announced.
- Reiterates FY2024 guidance: net sales $795-800M, adjusted EBITDA $64-69M.
- Introduces 2027 targets: 6-7% revenue CAGR, mid-teens adjusted EBITDA margin, positive FCF.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/884624/000095017024122777/0000950170-24-122777-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/884624/000095017024122777/ofix-20241107.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-122777

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer